This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders Europe
Save the dates 5-6 March 2025
Congress Center BaselBasel, Switzerland

Momentum Biotechnologies


Momentum Biotechnologies (“Momentum”) is a specialized CRO focused on providing mass spectrometry-based native detection technologies for lead discovery and the quantification of difficult targets to biopharmaceutical clients globally.

We are the leading provider of solution phase Affinity Selection Mass Spectrometry (ASMS) for RNA and protein targets. We help clients identify leads for novel mechanisms of action such as protein degradation/molecular glues, protein-protein interaction disruption (ASMS), and irreversible binding (Covalent Screening). We offer functional screens on RapidFire-MS, potency assays, and biomarker quantification and can additionally support Cell and Gene Therapy applications through ICP-MS analysis.

We have a large high throughput screening lab and a fully functional BL2 lab in Billerica, Massachusetts.

We're bringing you

  • Screening RNA Targets Using Mass Spec Binding Assays